Home
KROS
KROS News

Latest Keros Therapeutics Inc. (KROS) News on November 17, 2024

Keros Therapeutics Third Quarter 2024 Earnings: US$1.41 loss per share (vs US$1.33 loss in 3Q 2023)

Simply Wall St.

9 days ago

Keros Therapeutics Third Quarter 2024 Earnings: US$1.41 loss per share (vs US$1.33 loss in 3Q 2023)

Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2024 Financial Results

GlobeNewswire

11 days ago

Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2024 Financial Results

Keros Therapeutics to Present at the Guggenheim Healthcare Innovation Conference

GlobeNewswire

11 days ago

Keros Therapeutics to Present at the Guggenheim Healthcare Innovation Conference

Keros Therapeutics to Present at the 66th American Society of Hematology Annual Meeting and Exposition

GlobeNewswire

12 days ago

Keros Therapeutics to Present at the 66th American Society of Hematology Annual Meeting and Exposition

MT Newswires

24 days ago

Cantor Fitzgerald Initiates Keros Therapeutics at Overweight

MT Newswires

a month ago

Scotiabank Initiates Keros Therapeutics at Sector Outperform

Keros Therapeutics Appoints Yung H. Chyung, M.D., as Chief Medical Officer

GlobeNewswire

a month ago

Keros Therapeutics Appoints Yung H. Chyung, M.D., as Chief Medical Officer

MT Newswires

2 months ago

Guggenheim Initiates Keros Therapeutics at Buy With $96 Price Target

Keros Therapeutics Announces Updated Time of Presentation at 2024 Cantor Global Healthcare Conference

GlobeNewswire

2 months ago

Keros Therapeutics Announces Updated Time of Presentation at 2024 Cantor Global Healthcare Conference

Keros Therapeutics Stock Meets 80-Plus RS Rating Benchmark

Investor's Business Daily

2 months ago

Keros Therapeutics Stock Meets 80-Plus RS Rating Benchmark

Keros Therapeutics Announces Update on Enrollment in the Phase 2 TROPOS Trial

GlobeNewswire

2 months ago

Keros Therapeutics Announces Update on Enrollment in the Phase 2 TROPOS Trial

Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences

GlobeNewswire

3 months ago

Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences

MT Newswires

3 months ago

Keros Therapeutics Insider Sold Shares Worth $11,002,500, According to a Recent SEC Filing

Keros Therapeutics Reports Second Quarter 2024 Financial Results

GlobeNewswire

3 months ago

Keros Therapeutics Reports Second Quarter 2024 Financial Results

Companies Like Keros Therapeutics (NASDAQ:KROS) Are In A Position To Invest In Growth

Simply Wall St.

4 months ago

Companies Like Keros Therapeutics (NASDAQ:KROS) Are In A Position To Invest In Growth

MT Newswires

5 months ago

Oppenheimer Initiates Keros Therapeutics at Outperform With $102 Price Target

MT Newswires

5 months ago

Keros Therapeutics Names Chief Executive Officer Jasbir Seehra as Board Chair

Keros Therapeutics Announces Leadership Updates

GlobeNewswire

5 months ago

Keros Therapeutics Announces Leadership Updates

Keros Therapeutics Presents Clinical Data from its Elritercept (KER-050) Program at the 29th Annual Hybrid Congress of the European Hematology Association

GlobeNewswire

5 months ago

Keros Therapeutics Presents Clinical Data from its Elritercept (KER-050) Program at the 29th Annual Hybrid Congress of the European Hematology Association

Keros Therapeutics to Host a Corporate Update Conference Call and Webcast

GlobeNewswire

5 months ago

Keros Therapeutics to Host a Corporate Update Conference Call and Webcast

Keros Therapeutics to Present at Goldman Sachs 45th Annual Global Healthcare Conference

GlobeNewswire

5 months ago

Keros Therapeutics to Present at Goldman Sachs 45th Annual Global Healthcare Conference

Keros Therapeutics Appoints Jean-Jacques Bienaimé to its Board of Directors

GlobeNewswire

6 months ago

Keros Therapeutics Appoints Jean-Jacques Bienaimé to its Board of Directors

Keros Therapeutics to Present at the 29th Annual Congress of the European Hematology Association

GlobeNewswire

6 months ago

Keros Therapeutics to Present at the 29th Annual Congress of the European Hematology Association

Keros Therapeutics Reports Widening Losses in Q1 2024, Despite Progress in Clinical Trials

GuruFocus.com

6 months ago

Keros Therapeutics Reports Widening Losses in Q1 2024, Despite Progress in Clinical Trials

Keros Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results

GlobeNewswire

6 months ago

Keros Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results

Are Investors Undervaluing Keros Therapeutics, Inc. (NASDAQ:KROS) By 37%?

Simply Wall St.

7 months ago

Are Investors Undervaluing Keros Therapeutics, Inc. (NASDAQ:KROS) By 37%?

Keros Therapeutics Announces U.S. FDA Fast Track Designation for KER-050 in Lower-Risk Myelodysplastic Syndromes

GlobeNewswire

8 months ago

Keros Therapeutics Announces U.S. FDA Fast Track Designation for KER-050 in Lower-Risk Myelodysplastic Syndromes

Keros Therapeutics to Present at Leerink Partners 2024 Global Biopharma Conference

GlobeNewswire

8 months ago

Keros Therapeutics to Present at Leerink Partners 2024 Global Biopharma Conference

Keros Therapeutics Inc (KROS) Reports Increased R&D Spending and Net Loss in 2023

GuruFocus.com

9 months ago

Keros Therapeutics Inc (KROS) Reports Increased R&D Spending and Net Loss in 2023

Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire

9 months ago

Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results

Keros Therapeutics, Inc. (KROS) is on the Move, Here's Why the Trend Could be Sustainable

Zacks

9 months ago

Keros Therapeutics, Inc. (KROS) is on the Move, Here's Why the Trend Could be Sustainable

Does Keros Therapeutics, Inc. (KROS) Have the Potential to Rally 35.66% as Wall Street Analysts Expect?

Zacks

9 months ago

Does Keros Therapeutics, Inc. (KROS) Have the Potential to Rally 35.66% as Wall Street Analysts Expect?

Recent Price Trend in Keros Therapeutics, Inc. (KROS) is Your Friend, Here's Why

Zacks

9 months ago

Recent Price Trend in Keros Therapeutics, Inc. (KROS) is Your Friend, Here's Why

Wall Street Analysts Predict a 45.35% Upside in Keros Therapeutics, Inc. (KROS): Here's What You Should Know

Zacks

10 months ago

Wall Street Analysts Predict a 45.35% Upside in Keros Therapeutics, Inc. (KROS): Here's What You Should Know

Keros Therapeutics To Present at Pulmonary Vascular Research Institute 2024 Annual Congress

GlobeNewswire

10 months ago

Keros Therapeutics To Present at Pulmonary Vascular Research Institute 2024 Annual Congress

King Charles III spends third day in London hospital after prostate surgery

AFP

10 months ago

King Charles III spends third day in London hospital after prostate surgery

Girona take Liga lead back with win at Celta

AFP

10 months ago

Girona take Liga lead back with win at Celta

ICF International Inc Insider Sells Company Shares

GuruFocus.com

10 months ago

ICF International Inc Insider Sells Company Shares

Scotts Miracle-Gro (NYSE:SMG) investors are sitting on a loss of 72% if they invested three years ago

Simply Wall St.

10 months ago

Scotts Miracle-Gro (NYSE:SMG) investors are sitting on a loss of 72% if they invested three years ago

Associated Press Finance

10 months ago

Seacoast Banking: Q4 Earnings Snapshot

ICF Announces Timing of Fourth Quarter and Full Year 2023 Earnings Release and Conference Call

PR Newswire

10 months ago

ICF Announces Timing of Fourth Quarter and Full Year 2023 Earnings Release and Conference Call

Seacoast Reports Fourth Quarter and Full Year 2023 Results

GlobeNewswire

10 months ago

Seacoast Reports Fourth Quarter and Full Year 2023 Results

Oil Touches Two-Month High on US Stockpile Drop, China Stimulus

Bloomberg

10 months ago

Oil Touches Two-Month High on US Stockpile Drop, China Stimulus

20 Countries That Produce the Most Oil In The World

Insider Monkey

10 months ago

20 Countries That Produce the Most Oil In The World

Simmons First National Corporation (NASDAQ:SFNC) Q4 2023 Earnings Call Transcript

Insider Monkey

10 months ago

Simmons First National Corporation (NASDAQ:SFNC) Q4 2023 Earnings Call Transcript

Oil Climbs Above $75 as Winter Shut-Ins Lead to Big Stock Draw

Zacks

10 months ago

Oil Climbs Above $75 as Winter Shut-Ins Lead to Big Stock Draw

Keros Therapeutics, Inc. (NASDAQ:KROS) institutional owners may be pleased with recent gains after 2.4% loss over the past year

Simply Wall St.

10 months ago

Keros Therapeutics, Inc. (NASDAQ:KROS) institutional owners may be pleased with recent gains after 2.4% loss over the past year

Thomson Reuters StreetEvents

10 months ago

Q4 2023 Simmons First National Corp Earnings Call

Simmons First National Corp (SFNC) Announces Q4 2023 Earnings and Strategic Initiatives

GuruFocus.com

10 months ago

Simmons First National Corp (SFNC) Announces Q4 2023 Earnings and Strategic Initiatives

Here's What Key Metrics Tell Us About Simmons First National (SFNC) Q4 Earnings

Zacks

10 months ago

Here's What Key Metrics Tell Us About Simmons First National (SFNC) Q4 Earnings

Keros Therapeutics, Inc. (KROS) Is a Great Choice for 'Trend' Investors, Here's Why

Zacks

10 months ago

Keros Therapeutics, Inc. (KROS) Is a Great Choice for 'Trend' Investors, Here's Why

Amcor to report Half Year 2024 results

PR Newswire

10 months ago

Amcor to report Half Year 2024 results

Keros Therapeutics, Inc. (KROS) Just Flashed Golden Cross Signal: Do You Buy?

Zacks

10 months ago

Keros Therapeutics, Inc. (KROS) Just Flashed Golden Cross Signal: Do You Buy?

Cinemark’s Annual Oscar® Movie Week Festival Brings Prestigious Hollywood Films to Auditoriums Across the Nation

Business Wire

10 months ago

Cinemark’s Annual Oscar® Movie Week Festival Brings Prestigious Hollywood Films to Auditoriums Across the Nation

Survey Reveals 55% of CXM Leaders Plan to Invest $1 Million or more in GenAI in Next 12-18 Months

Business Wire

10 months ago

Survey Reveals 55% of CXM Leaders Plan to Invest $1 Million or more in GenAI in Next 12-18 Months

Spotting Winners: Box (NYSE:BOX) And Productivity Software Stocks In Q3

StockStory

10 months ago

Spotting Winners: Box (NYSE:BOX) And Productivity Software Stocks In Q3

Director Sarah Rouan Sells 30,000 Shares of Viking Therapeutics Inc

GuruFocus.com

10 months ago

Director Sarah Rouan Sells 30,000 Shares of Viking Therapeutics Inc

San Francisco's largest mall loses more retailers as exodus continues

Fox Business

10 months ago

San Francisco's largest mall loses more retailers as exodus continues

Why Liberty Oilfield Services (LBRT) is a Top Value Stock for the Long-Term

Zacks

10 months ago

Why Liberty Oilfield Services (LBRT) is a Top Value Stock for the Long-Term

Coursera to Announce Fourth Quarter and Full Year 2023 Financial Results

Business Wire

10 months ago

Coursera to Announce Fourth Quarter and Full Year 2023 Financial Results

We're Keeping An Eye On Ultragenyx Pharmaceutical's (NASDAQ:RARE) Cash Burn Rate

Simply Wall St.

10 months ago

We're Keeping An Eye On Ultragenyx Pharmaceutical's (NASDAQ:RARE) Cash Burn Rate

Mueller Water Products Nominates Brian Healy to Join its Board of Directors

GlobeNewswire

10 months ago

Mueller Water Products Nominates Brian Healy to Join its Board of Directors

Earnings Estimates Rising for GoodRx Holdings, Inc. (GDRX): Will It Gain?

Zacks

10 months ago

Earnings Estimates Rising for GoodRx Holdings, Inc. (GDRX): Will It Gain?

Elevations Credit Union Launches with Alkami's Online Retail, Business and Mobile Banking

PR Newswire

10 months ago

Elevations Credit Union Launches with Alkami's Online Retail, Business and Mobile Banking

Streetwise: The Trouble With Bitcoin ETFs

The Wall Street Journal

10 months ago

Streetwise: The Trouble With Bitcoin ETFs

How Much Upside is Left in Keros Therapeutics, Inc. (KROS)? Wall Street Analysts Think 57.46%

Zacks

10 months ago

How Much Upside is Left in Keros Therapeutics, Inc. (KROS)? Wall Street Analysts Think 57.46%

SEC Had a Fraught Cyber Record Before X Account Was Hacked

Bloomberg

10 months ago

SEC Had a Fraught Cyber Record Before X Account Was Hacked

AvidXchange Holdings, Inc. (AVDX) Gains But Lags Market: What You Should Know

Zacks

10 months ago

AvidXchange Holdings, Inc. (AVDX) Gains But Lags Market: What You Should Know

With 62% ownership of the shares, AvidXchange Holdings, Inc. (NASDAQ:AVDX) is heavily dominated by institutional owners

Simply Wall St.

10 months ago

With 62% ownership of the shares, AvidXchange Holdings, Inc. (NASDAQ:AVDX) is heavily dominated by institutional owners

After Golden Cross, Ultragenyx (RARE)'s Technical Outlook is Bright

Zacks

10 months ago

After Golden Cross, Ultragenyx (RARE)'s Technical Outlook is Bright

Keros Therapeutics Announces Closing of Upsized Public Offering of Common Stock

GlobeNewswire

10 months ago

Keros Therapeutics Announces Closing of Upsized Public Offering of Common Stock

Brady Corp's Dividend Analysis

GuruFocus.com

10 months ago

Brady Corp's Dividend Analysis

SpringWorks Therapeutics Highlights 2023 Accomplishments and Anticipated Milestones for 2024 at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

10 months ago

SpringWorks Therapeutics Highlights 2023 Accomplishments and Anticipated Milestones for 2024 at the 42nd Annual J.P. Morgan Healthcare Conference

Warren Buffett's Berkshire Bolsters Holdings in Liberty SiriusXM Group Acquisition

GuruFocus.com

10 months ago

Warren Buffett's Berkshire Bolsters Holdings in Liberty SiriusXM Group Acquisition

Berkshire Buys More Liberty SiriusXM Tracking Stock

Barrons.com

10 months ago

Berkshire Buys More Liberty SiriusXM Tracking Stock

Zacks Industry Outlook Highlights Alarm.com, Brady, Napco Security Technologies and Lakeland Industries

Zacks

10 months ago

Zacks Industry Outlook Highlights Alarm.com, Brady, Napco Security Technologies and Lakeland Industries

HASI Invests in 605 MW Renewables Portfolio Owned and Operated by AES

Business Wire

10 months ago

HASI Invests in 605 MW Renewables Portfolio Owned and Operated by AES

Keros Therapeutics Announces Pricing of Upsized Public Offering of Common Stock

GlobeNewswire

10 months ago

Keros Therapeutics Announces Pricing of Upsized Public Offering of Common Stock

Business Wire

a year ago

FCPT Announces Sale-Leaseback of a Tire Discounters Property for $1.8 Million

BGC stock jumps on upbeat Q4 outlook

Yahoo Finance Video

a year ago

BGC stock jumps on upbeat Q4 outlook

Why TransMedics (TMDX) Stock Might be a Great Pick

Zacks

a year ago

Why TransMedics (TMDX) Stock Might be a Great Pick

BGC Group Updates its Outlook for the Fourth Quarter of 2023 and Provides Update to FMX Announcement Timing

PR Newswire

a year ago

BGC Group Updates its Outlook for the Fourth Quarter of 2023 and Provides Update to FMX Announcement Timing

Business Wire

a year ago

FCPT Announces Acquisition of Two Popeyes Properties for $4.7 Million

TipRanks’ ‘Perfect 10’ List: These 3 Top-Scoring Stocks Are Poised to Perform in 2024

TipRanks

a year ago

TipRanks’ ‘Perfect 10’ List: These 3 Top-Scoring Stocks Are Poised to Perform in 2024

Business Wire

a year ago

FCPT Announces Sale-Leaseback of a Tire Discounters Property for $1.7 Million

Reasons to Add Otter Tail (OTTR) to Your Portfolio Right Now

Zacks

a year ago

Reasons to Add Otter Tail (OTTR) to Your Portfolio Right Now

Wall Street Analysts Believe Arvinas, Inc. (ARVN) Could Rally 42.05%: Here's is How to Trade

Zacks

a year ago

Wall Street Analysts Believe Arvinas, Inc. (ARVN) Could Rally 42.05%: Here's is How to Trade

Visteon Corp CEO Sachin Lawande Sells Company Shares

GuruFocus.com

a year ago

Visteon Corp CEO Sachin Lawande Sells Company Shares

ICF International (ICFI) Rises 34.8% in a Year: Here's How

Zacks

a year ago

ICF International (ICFI) Rises 34.8% in a Year: Here's How

13 Most Profitable Renewable Energy Stocks

Insider Monkey

a year ago

13 Most Profitable Renewable Energy Stocks

SpringWorks Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

a year ago

SpringWorks Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

12 Most Promising Cancer Stocks According to Analysts

Insider Monkey

a year ago

12 Most Promising Cancer Stocks According to Analysts

Otter Tail's (NASDAQ:OTTR) three-year earnings growth trails the 26% YoY shareholder returns

Simply Wall St.

a year ago

Otter Tail's (NASDAQ:OTTR) three-year earnings growth trails the 26% YoY shareholder returns

Has Arvinas (ARVN) Outpaced Other Medical Stocks This Year?

Zacks

a year ago

Has Arvinas (ARVN) Outpaced Other Medical Stocks This Year?

Those who invested in SeaWorld Entertainment (NYSE:SEAS) five years ago are up 85%

Simply Wall St.

a year ago

Those who invested in SeaWorld Entertainment (NYSE:SEAS) five years ago are up 85%

3 Niche Tech Stocks With Untapped Potential

InvestorPlace

a year ago

3 Niche Tech Stocks With Untapped Potential

Insider Sell: Kenneth Moelis Unloads Shares of Moelis & Co

GuruFocus.com

a year ago

Insider Sell: Kenneth Moelis Unloads Shares of Moelis & Co

Business Wire

a year ago

FCPT Announces Fourth Quarter 2023 Dividend

PJT Partners Inc. (NYSE:PJT) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

PJT Partners Inc. (NYSE:PJT) Q3 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

a year ago

Q3 2023 PJT Partners Inc Earnings Call

Share on Social Networks: